Strides Pharma Science

Sector: Healthcare

Followers

0
0
7
7
.
4
4
3
3
9
9
82.30 (9.66%)

As on 31 Oct, 2025 | 15:59

Open Trading A/c
Day Range
830.30
978.40
LH
52 Week Range
513.05
1,655.00
LH
Volume
* i
Bid / Ask
9,220,861.00
0.00 / 0.00

Strides Pharma Science Announcements

Newspaper advertisement - Unaudited financial results of the Company for the quarter and half year ended September 30, 2025

01 Nov, 2025 | 04:15pm • Source: BSE

Audio Recording of Earnings Call pertaining to the Unaudited Financial Results for the quarter and half year ended September 30, 2025

31 Oct, 2025 | 08:56pm • Source: BSE

Strides Pharma Science Limited has informed the Exchange regarding a press release dated October 31, 2025, titled "Strides Delivers a Robust Q2FY26 with Highest Ever...

31 Oct, 2025 | 01:53pm • Source: NSE

Strides Pharma Science Limited has submitted to the Exchange, the financial results for the period ended September 30, 2025

31 Oct, 2025 | 01:52pm • Source: NSE

Outcome of Board Meeting held on October 31, 2025 - Press Release and Earnings Presentation

31 Oct, 2025 | 01:07pm • Source: BSE

Outcome of Board Meeting - Unaudited Financial Results (Consolidated & Standalone) for the quarter and half year ended September 30, 2025

31 Oct, 2025 | 01:05pm • Source: BSE

Earnings Call to discuss unaudited financial results of the Company for the quarter and half-year ended September 30, 2025.

24 Oct, 2025 | 09:46pm • Source: BSE

Strides Pharma Science Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 31/10/2025 ,inter alia, to consider...

24 Oct, 2025 | 06:55pm • Source: BSE

Strides and Incepta Partner to Expand Women''s Health Access with WHO-Prequalified Contraceptive

17 Oct, 2025 | 03:19pm • Source: BSE

Intimation regarding Closure of Trading Window for Q2 and Half Year - FY26

25 Sep, 2025 | 02:57pm • Source: BSE

Strides'' Sustainability Report for FY25

24 Sep, 2025 | 11:01am • Source: BSE

2nd Reminder to Shareholders whose shares are due to be transferred to IEPF

19 Sep, 2025 | 06:02pm • Source: BSE

Schedule of Analyst/ Institutional Investors'' Meet

17 Sep, 2025 | 06:39pm • Source: BSE

Strides Enters into a Strategic Product Development Partnership with Kenox to Expand Nasal Spray Portfolio for the US Market

08 Sep, 2025 | 06:22pm • Source: BSE

Intimation under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 - Schedule of Analyst/ Institutional Investor's Meet

26 Aug, 2025 | 05:36pm • Source: BSE

Deregistration of a non-operating step-down subsidiary of the Company in South Africa.

25 Aug, 2025 | 05:28pm • Source: BSE

Intimation regarding Voting Results and Scrutinizer Report of 34th Annual General Meeting of the Company

08 Aug, 2025 | 09:09pm • Source: BSE

We would like to inform you that Management of Strides will be attending investor conference organised by Emkay Global Financial Services Limited on August 12,...

07 Aug, 2025 | 08:25pm • Source: BSE

Proceedings of 34th Annual General Meeting of the Company

07 Aug, 2025 | 04:32pm • Source: BSE

Transcript of Earnings Call pertaining to unaudited financial results of the Company for the quarter ended June 30 2025

04 Aug, 2025 | 07:08pm • Source: BSE